Literature DB >> 5051680

Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.

E L Middleman, A Watanabe, H Kaizer, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5051680     DOI： 10.1002/1097-0142(197208)30:2<573::aid-cncr2820300238>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  19 in total

1.  Measurement of bactericidal activity in body fluids as a clinical research procedure.

Authors:  P Dejace; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

2.  In vitro killing of erythromycin-exposed group A streptococci by polymorphonuclear leukocytes.

Authors:  H Pruul; B Wetherall; P McDonald
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 3.  Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.

Authors:  J W Hathorn; M Rubin; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.

Authors:  J Klastersky; C Hensgens; L Debusscher
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

5.  Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.

Authors:  Akiko Nakamura; Yuka Sugimoto; Kohshi Ohishi; Yumiko Sugawara; Atsushi Fujieda; Fumihiko Monma; Kei Suzuki; Masahiro Masuya; Kazunori Nakase; Yoshiko Matsushima; Hideo Wada; Naoyuki Katayama; Tsutomu Nobori
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

Review 6.  [A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].

Authors:  P Dejace; J Klastersky
Journal:  Infection       Date:  1987       Impact factor: 3.553

7.  Imipenem-cilastatin as initial therapy for febrile cancer patients.

Authors:  G P Bodey; M E Alvarez; P G Jones; K V Rolston; L Steelhammer; V Fainstein
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

8.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

9.  Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.

Authors:  D M Hahn; S C Schimpff; V M Young; C L Fortner; H C Standiford; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

10.  Mezlocillin for treatment of infections in cancer patients.

Authors:  B F Issell; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.